A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer

By Ahmed Mohamed   Aleskandarany Mohammed   Rakha Emad   Moustafa Radwa   Benhasouna Ahmed   Nolan Christopher   Green Andrew   Ilyas Mohammad   Ellis Ian  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 979-995

Springer Publishing Company

Access to resources Recommend Favorite

Serum amyloid A: A new potential serum marker correlated with the stage of breast cancer

By          

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 940-944

Spandidos Publications

Access to resources Recommend Favorite

TIMP-1 as a tumor marker in breast cancer - An update

By Wurtz Sidse   Schrohl Anne-Sofie   Mouridsen Henning   Brunner Nils  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 580-590

Informa Healthcare

Access to resources Recommend Favorite

Strategies to Decrease Taxanes Toxicities in the Adjuvant Treatment of Early Breast Cancer

By Tang Shou-Ching  

Cancer Investigation, Vol. 27, Iss. 2, 2009-02 ,pp. : 206-214

Informa Healthcare

Access to resources Recommend Favorite

Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer

By Dean-Colomb Windy  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 631-636

Springer Publishing Company

Access to resources Recommend Favorite